Prevalence of Colon Cancer in Pyogenic Liver Abscess

Cryptogenic Pyogenic Liver Abscess Clinical Trial

Official title:

The Prevalence of Colonic Neoplasm in Cryptogenic Pyogenic Liver Abscess

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02032914
• Other study ID #: 1
• Status: Completed
• Phase: Phase 4
• First received: January 8, 2014
• Last updated: February 26, 2016
• Start date: January 2014
• Est. completion date: February 2016

Study information

• Verified date: February 2016
• Source: Inje University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Ministry for Health and Welfare
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Although a proportion of pyogenic liver abscess may originated from colonic mucosal lesions, the prevalence of colonic neoplasm in the patients with pyogenic liver abscess are still not evaluated yet. Thus, our group will find the prevalence of colonic neoplasm in the group of cryptogenic pyogenic liver abscess by colonoscopic examination.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 62
• Est. completion date: February 2016
• Est. primary completion date: February 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Pyogenic liver abscess radiologically and bacteriologically diagnosed

Exclusion Criteria:

• Amebic liver abscess

• Other causes of pyogenic liver abscess such as cholangitis, liver cancer, complication of transarterial chemoembolization or radiofrequency ablation to hepatocellular carcinoma

• Refusal to colonoscopic examination

• Inadequate general patient status to perform the colonoscopic examination

• Patient who has had the screening colonoscopic examination within 1 year and showed normal finding or had 1 or 2 colon polyp in adequate exam

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Abscess
• Cryptogenic Pyogenic Liver Abscess
• Liver Abscess
• Liver Abscess, Pyogenic

Locations

Country	Name	City	State
Korea, Republic of	Inje University Haeundae Paik Hospital	Busan
Korea, Republic of	Pusan National Unversity Yangsan Hospital	Yangsan-si	Gyeongsangnam-do

Sponsors (2)

Lead Sponsor	Collaborator
Inje University	Pusan National University Yangsan Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The prevalence of colonic neoplasm		within 6 weeks after diagnosis of pyogenic liver abscess	No
Secondary	Prevalence of colon polyp		Within 6 weeks at diagnosis of pyogenic liver abscess	No
Secondary	Prevalence of colonic diverticulitis		Within 6 weeks at diagnosis of pyogenic liver abscess	No
Secondary	Prevalence of inflammatory bowel disease		Within 6 weeks at diagnosis of pyogenic liver abscess	No
Secondary	Prevalence of intestinal tuberculosis		Within 6 weeks at diagnosis of pyogenic liver abscess	No